---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-026593"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T02:35:16.149423+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BioCardia reports Q3 net loss $8.9M, DSMB supports adaptive design for heart failure trial

## Summary
- 9-month revenue $1.2M (up from $0.9M), net loss $8.9M, operating cash burn $7.6M.
- CardiAMP heart failure trial DSMB recommends adaptive statistical plan for early readout; 100% survival at 2 years in roll-in cohort.
- IND filed for NK1R+ MSC for heart failure (BCDA-03); FDA approval anticipated Dec 2022.
- First manufacturing batch for ARDS program (BCDA-04) completed; first patient treatment expected Q4 2022.
- BlueRock partnership for cell delivery; upfront payment received, option for worldwide license.

## SEC filing metadata
- accession: 0001437749-22-026593
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774922026593/0001437749-22-026593-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774922026593/bcda20221108_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-026593
- JSON: https://secwatch.observer/filing/0001437749-22-026593.json
- Plain text: https://secwatch.observer/filing/0001437749-22-026593.txt

## Key facts
- Earnings Releases
  BioCardia, Inc. reported financial results for the quarter ended September 30, 2022.
  - Period: the quarter ended September 30, 2022
  - Result: reported results
  source text: On November 9, 2022, BioCardia, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/925741/000143774922026593/0001437749-22-026593-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.